KMX
58
-3
M
50
2
COF
62
-5
KIM
48
-6
HP
30
-2
ABT
48
3
AMAT
60
-3
PCAR
53
-3
DOV
79
-4
MMC
70
3
VRSK
84
9
PGR
67
-2
AMZN
69
4
DVA
72
-3
GPC
40
-3
THC
75
-4
CAT
66
-6
IP
65
3
CINF
54
3
CA
28
-16
KMX
58
-3
M
50
2
COF
62
-5
KIM
48
-6
HP
30
-2
ABT
48
3
AMAT
60
-3
PCAR
53
-3
DOV
79
-4
MMC
70
3
VRSK
84
9
PGR
67
-2
AMZN
69
4
DVA
72
-3
GPC
40
-3
THC
75
-4
CAT
66
-6
IP
65
3
CINF
54
3
CA
28
-16
Financhill
Back

Ansell Vs. Kazia Therapeutics Industry Stock Comparison

Sell
42

ANSLY
Ansell

Last Price:
63.17
Seasonality Move:
3.41%
Sell
35

KZIA
Kazia Therapeutics

Last Price:
0.29
Seasonality Move:
-16.46%
Sell
42
Ansell (ANSLY) is a Sell

Is Ansell a Buy, Sell or Hold?

  • The current Ansell [ANSLY] share price is $63.17. The Score for ANSLY is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • ANSLY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
Kazia Therapeutics (KZIA) is a Sell

Is Kazia Therapeutics a Buy, Sell or Hold?

  • The current Kazia Therapeutics [KZIA] share price is $0.29. The Score for KZIA is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • KZIA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ANSLY Stock Price Chart

What is Ansell's stock price today?

  • The Ansell share price today is $63.17
    The current trend is relatively stagnant and ANSLY is experiencing slight buying pressure.

KZIA Stock Price Chart

What is Kazia Therapeutics's stock price today?

  • The Kazia Therapeutics share price today is $0.29
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KZIA is experiencing slight buying pressure.

ANSLY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0 Buy
Relative Strength Index (14 RSI): 50.16 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (63.17 - 63.17) Sell
Bollinger Bands (100): (62.1 - 65) Sell

KZIA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 45.55 Sell
Chaikin Money Flow: 55038 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.28 - 0.36) Sell
Bollinger Bands (100): (0.26 - 0.38) Sell

ANSLY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 63.17 Sell
20-day SMA: 63.17 Sell
50-day SMA: 63.16 Buy
200-day SMA: 61.42 Buy
8-day EMA: 63.17 Buy
20-day EMA: 63.17 Buy
50-day EMA: 63.16 Buy
200-day EMA: 63.72 Sell

KZIA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.29 Buy
20-day SMA: 0.32 Sell
50-day SMA: 0.31 Sell
200-day SMA: 0.54 Sell
8-day EMA: 0.29 Buy
20-day EMA: 0.31 Sell
50-day EMA: 0.32 Sell
200-day EMA: 0.57 Sell

Ansell Earnings Growth & ANSLY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Kazia Therapeutics Earnings Growth & KZIA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.03 per share, and an increase next year of $0.01 per share.

Ansell Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kazia Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):